Our Products

Dasatinib Tablets 100 mg is a medication used to treat chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL), particularly in patients with the Philadelphia chromosome-positive (Ph+) mutation. It is a tyrosine kinase inhibitor that works by blocking the BCR-ABL fusion protein, a key driver of cancer cell growth in these types of leukemia. By inhibiting this protein, Dasatinib helps slow or stop the proliferation of cancer cells.

The 100 mg dosage is typically taken once daily, but the exact dosing schedule may depend on the individual patient’s condition and response to treatment. Common side effects include fluid retention, fatigue, headache, nausea, diarrhea, and low blood cell counts. Regular monitoring of blood counts, liver function, and other vital parameters is necessary to manage side effects and ensure the treatment’s effectiveness.